Double blind controlled trial of effect of cisapride on gastric emptying in diabetics.
dc.contributor.author | Dutta, U | en_US |
dc.contributor.author | Padhy, A K | en_US |
dc.contributor.author | Ahuja, V | en_US |
dc.contributor.author | Sharma, M P | en_US |
dc.date.accessioned | 1999-07-01 | en_US |
dc.date.accessioned | 2009-06-04T04:43:55Z | |
dc.date.available | 1999-07-01 | en_US |
dc.date.available | 2009-06-04T04:43:55Z | |
dc.date.issued | 1999-07-01 | en_US |
dc.description.abstract | AIMS: Diabetic gastroparesis is a common complication seen in 20-50% of patients due to autonomic neuropathy involving vagal supply. Cisapride, a specific gastrointestinal cholinomimetic agent may thus be effective. METHODS: Fifty-one diabetic patients (age 12-65 years) of disease duration > 5 years were assessed for symptomatic gastroparesis, other diabetic complications and glycemic control. Gastric emptying time (GET) was estimated using a solid meal method (99mTc labeled rice based idli) and patients randomized to receive either cisapride or placebo for a period of 2 weeks. Cisapride was administered in a dose of 10 mg TID. GET and symptom scores were reassessed on the therapy after 2 weeks. RESULTS: Twenty nine of 51 (56.8%) patients had gastroparesis. Mean GET in the gastroparesis group was 141 +/- 66 minutes compared to 24.53 +/- 10 minutes in the non gastroparesis group (p < 0.01). GET decreased by 72% amongst the patients who received cisapride compared to 23% in the placebo group (p < 0.001). Symptom scores also improved in the cisapride group; no adverse effects were noted. CONCLUSIONS: Cisapride improves the symptom score and the solid gastric emptying time in patients suffering from diabetic gastroparesis. | en_US |
dc.description.affiliation | All India Institute of Medical Sciences, New Delhi, India. | en_US |
dc.identifier.citation | Dutta U, Padhy AK, Ahuja V, Sharma MP. Double blind controlled trial of effect of cisapride on gastric emptying in diabetics. Tropical Gastroenterology. 1999 Jul-Sep; 20(3): 116-9 | en_US |
dc.identifier.uri | https://imsear.searo.who.int/handle/123456789/125112 | |
dc.language.iso | eng | en_US |
dc.source.uri | https://www.tropicalgastro.com | en_US |
dc.subject.mesh | Adolescent | en_US |
dc.subject.mesh | Adult | en_US |
dc.subject.mesh | Aged | en_US |
dc.subject.mesh | Child | en_US |
dc.subject.mesh | Cisapride --therapeutic use | en_US |
dc.subject.mesh | Diabetic Neuropathies --complications | en_US |
dc.subject.mesh | Double-Blind Method | en_US |
dc.subject.mesh | Gastric Emptying --drug effects | en_US |
dc.subject.mesh | Gastrointestinal Agents --therapeutic use | en_US |
dc.subject.mesh | Gastroparesis --drug therapy | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Middle Aged | en_US |
dc.title | Double blind controlled trial of effect of cisapride on gastric emptying in diabetics. | en_US |
dc.type | Clinical Trial | en_US |
dc.type | Journal Article | en_US |
dc.type | Randomized Controlled Trial | en_US |
Files
License bundle
1 - 1 of 1